Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001043126 | SCV001206842 | uncertain significance | Xeroderma pigmentosum, group F; Cockayne syndrome; Fanconi anemia complementation group Q | 2023-07-06 | criteria provided, single submitter | clinical testing | This variant is present in population databases (rs368830992, gnomAD 0.008%). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt ERCC4 protein function. ClinVar contains an entry for this variant (Variation ID: 840996). This variant has not been reported in the literature in individuals affected with ERCC4-related conditions. This sequence change replaces serine, which is neutral and polar, with leucine, which is neutral and non-polar, at codon 540 of the ERCC4 protein (p.Ser540Leu). |
Institute for Clinical Genetics, |
RCV003238281 | SCV002009709 | uncertain significance | not provided | 2021-11-03 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV002259070 | SCV002537730 | uncertain significance | Xeroderma pigmentosum | 2021-08-17 | criteria provided, single submitter | curation | |
Gene |
RCV003238281 | SCV005331812 | uncertain significance | not provided | 2023-07-20 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |